Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment beQuoted
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment DirectorsTalk Interviews
GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment TipRanks
Currently, hormonal therapy for endometriosis faces challenges in achieving a balance between treatment and preserving the chance of pregnancy. Therefore, the development of non-hormonal therapy holds significant clinical importance. Angiogenesis …
Endometriosis is a widely spread disease that affects about 8% of the world's female population. This condition may be described as a spread of endometrial tissue apart from the uterine …
A 25-year-old unmarried woman with sex experience was referred to our hospital for the treatment of mild pneumothorax. On pneumothorax recurrence, thoracoscopy showed no cystic lesions on the visceral pleura …
BEYOND THE SCALPEL: ROBOTIC SURGERY INNOVATES FIBROIDS, ENDOMETRIOSIS TREATMENT The Star Online
A nulliparous woman in her 40s is referred to gynaecological oncology secondary to umbilical pain and bleeding with menses. Examination revealed a blood-filled cystic mass within an umbilical hernia consistent …
This study aimed to assess the causal relationship between lipidome and female reproductive diseases (FRDs) using an advanced series of Mendelian randomization (MR) methods. This study utilized genome-wide association study …